Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive asian study aims to create early warning system for child sepsis

NCT ID NCT07397689

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study will enroll 40,000 children under 18 with suspected infections across Asia to develop and validate an early recognition tool for sepsis. Researchers will test the Phoenix Sepsis Score and create a new toolkit (SORT) to help doctors identify sepsis earlier. The goal is to improve survival by catching the condition sooner in diverse healthcare settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Children \< 18 years old with suspected infection. Suspected infection is defined as children who undergo blood cultures and receive broad-spectrum anti-microbial agents in the first 24 hours of admission. Anti-microbial agents include antibiotics, antiviral, antifungal and antimalarial medications.

Ages

Up to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children \< 18 years old * Suspected infection defined by (1) blood culture performed (irrespective of result), AND (2) use of broad-spectrum anti-microbial agents, in the first 24 hours of admission Exclusion Criteria: * 18 years and older * Patients who discharge At Own Risk (AOR) without outcome data

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    19 sites in 9 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aga Khan University

    NOT_YET_RECRUITING

    Karachi, Pakistan

  • Chang Gong Memorial Hospital

    NOT_YET_RECRUITING

    Taipei, Taiwan

  • Hospital Pulau Pinang

    NOT_YET_RECRUITING

    George Town, Malaysia

  • Hospital Sultan Idris Shah

    NOT_YET_RECRUITING

    Serdang, Malaysia

  • Hospital Sultanah Aminah Johor Bahru

    NOT_YET_RECRUITING

    Johor Bahru, Malaysia

  • Hospital Tengku Ampuan Rahimah

    RECRUITING

    Klang, Malaysia

  • Hospital Tunku Azizah (Hospital Wanita dan Kanak-Kanak Kuala Lumpur)

    NOT_YET_RECRUITING

    Kuala Lumpur, Malaysia

  • Hospital Umum Sarawak

    NOT_YET_RECRUITING

    Kuching, Malaysia

  • KK Women's and Children' Hospital

    RECRUITING

    Singapore, 229899, Singapore

  • King Abdullah Specialist Children's Hospital

    NOT_YET_RECRUITING

    Riyadh, Saudi Arabia

  • King Chulalongkorn Memorial Hospital

    RECRUITING

    Bangkok, Thailand

  • National Taiwan University Hospital

    RECRUITING

    Taipei, Taiwan

  • National University Hospital

    RECRUITING

    Singapore, Singapore

  • Prince of Wales Hospital, The Chinese University of Hong Kong

    NOT_YET_RECRUITING

    Hong Kong, Hong Kong

  • Ramathibodi Hospital, Mahidol University

    NOT_YET_RECRUITING

    Bangkok, Thailand

  • Shanghai Children's Medical Center, Shanghai Jiaotong University

    NOT_YET_RECRUITING

    Shanghai, China

  • The National Children's Hospital

    NOT_YET_RECRUITING

    Hanoi, Vietnam

  • UKM: Hospital Tunku Ampuan Besar Tuanku Aishah Rohani

    NOT_YET_RECRUITING

    Kuala Lumpur, Malaysia

  • University Malaya Medical Centre (UMMC)

    NOT_YET_RECRUITING

    Kuala Lumpur, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.